Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

A Digital Support to Facilitate Sustainable Return to Work for Persons With Chronic Pain and Their Employers (SWEPPE)

9 de marzo de 2022 actualizado por: Mathilda Björk, Linkoeping University

An Evidence-based Digital Support for One Year to Facilitate a Sustainable Return to Work for Persons With Chronic Musculoskeletal Pain and Their Employers: Study Protocol for a Registry-based Multicentre Randomized Controlled Trial.

Chronic musculoskeletal pain (CMSP) severely affects the individual's quality of life, functioning and ability to work, and comes with significant societal costs for sick leave and loss of productivity. After completing an Interdisciplinary Pain Rehabilitation Program (IPRP), patients with CMSP experience a gap in the return to work (RTW) process when the responsibility for RTW is taken over by the employer. To fill this gap, we aim to evaluate the clinical effectiveness of a digital support (SWEPPE) for promoting a sustainable RTW for persons with CMSP and to facilitate the employers' supportive role and responsibilities in the process. Our hypothesis is that using SWEPPE will decrease the need for sick-leave.

SWEPPE is a smartphone application where the individual can create an action plan, perform daily registrations of health aspects, self-monitoring of health aspects and goals, have access to a library with evidence-based facts and a coach, and the possibility to share information with the employer.The employer access SWEPPE via a web application.

In this trial, we will recruit patients with CMSP aged 18-65 years who have completed IPRP, and who need support during RTW or continued support at the work placement for creating a sustainable work situation. The participants will be randomly assigned to either receive SWEPPE or to the control group. The intervention group will use SWEPPE during twelve months and the control group will not receive any active intervention for RTW which is standard clinical practice. Participants will be recruited from specialist and primary care level units connected to the Swedish National Quality Registry for Pain Rehabilitation (SQRP) and providing IPRP for patients with CMSP.

All participants will fill in questionnaires when they have completed the rehabilitation program and before the intervention starts. Study ending assessment will be performed after twelve months.

The clinical effectiveness of SWEPPE will be assessed by number of days with sickness cash benefit. Several dimensions of sick-leave will be assessed according to the Swedish Social Insurance Agency's (SSIA) proposal of outcome measures of RTW. Other outcomes and explanatory variables including important domains affected by CMSP such as health-related quality of life, functioning and work ability will be collected. A sample size calculation indicates the need for recruiting 360 participants (n=180 for each group).

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Anticipado)

360

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Mathilda Björk, PhD
  • Número de teléfono: +4611363531
  • Correo electrónico: mathilda.bjork@liu.se

Ubicaciones de estudio

      • Danderyd, Suecia, 182 57
        • Reclutamiento
        • Danderyd Hospital
      • Karlstad, Suecia
        • Aún no reclutando
        • Smärtcentrum
      • Linköping, Suecia, 581 83
        • Reclutamiento
        • County council of Ostergotland
      • Lund, Suecia
        • Aún no reclutando
        • Smärtcentrum
      • Stockholm, Suecia
        • Aún no reclutando
        • Spine Center

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 65 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

Patients entering the trial must have completed IPRP. The principal inclusion criteria for IPRP in Sweden are:

  • persistent or intermittent pain lasting ≥3 months
  • pain affecting daily activities to a large extent,
  • completed systematic assessment and non-pharmacological optimization is completed,
  • screening for psychosocial risk factors and differential diagnosis completed

In addition the following criteria will be applied:

  • Completed participation in an Interdisciplinary Pain Rehabilitation Program (IPRP) at any of the participating units.
  • Having an employment to return to after IPRP or having returned to work but need continued support for creating a sustainable work situation after IPRP.

Exclusion criteria:

  • Completed IPRP but are unemployed or unable to return to work.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: SWEPPE
Participants will receive the smartphone application SWEPPE.
In the smartphone application SWEPPE the individual can create an action plan, perform daily registrations of health aspects, self-monitoring of health aspects and goals, have access to a library with evidence-based facts and a coach, and possibility to share information with the employer.
Sin intervención: Control
Participants randomized to the control group will not receive any active intervention for return to work after completing an Interdisciplinary Pain Rehabilitation Program .

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Sick leave
Periodo de tiempo: 12 months follow up after IPRP
Number of gross and net days with sickness cash benefit
12 months follow up after IPRP

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Return to work
Periodo de tiempo: 12 months follow up after IPRP
Return to work (partially or full time) every month
12 months follow up after IPRP
Sick-leave spells per months
Periodo de tiempo: 12 months follow up after IPRP
Number of sick-leave spells (per month)
12 months follow up after IPRP
Return to work group level
Periodo de tiempo: 12 months follow up after IPRP
Proportions of a group who returns to full- or part-time work (per month)
12 months follow up after IPRP
Working days before new sick leave
Periodo de tiempo: 12 months follow up after IPRP
Number of days in work before new sick leave during study period
12 months follow up after IPRP
Proportion back to work
Periodo de tiempo: 12 months follow up after IPRP
Proportion of a group back to work >28 days (full- or part time) before a new sick-leave spell occurs
12 months follow up after IPRP
Total sick-leave spells
Periodo de tiempo: 12 months follow up after IPRP
Number of sick-leave spells during study period
12 months follow up after IPRP
Length of total sick leave
Periodo de tiempo: 12 months follow up after IPRP
Length of total sick leave during study period
12 months follow up after IPRP
Pain intensity last 7 days
Periodo de tiempo: Baseline and 12 months
Numeric rating scale
Baseline and 12 months
Consequences of pain on daily life
Periodo de tiempo: Baseline and 12 months
Multidimensional Pain Inventory Swedish version
Baseline and 12 months
Overall emotional distress
Periodo de tiempo: Baseline and 12 months
Hospital Anxiety and Depression Scale Swedish version
Baseline and 12 months
Physical and mental health
Periodo de tiempo: Baseline and 12 months
RAND-36 Swedish version
Baseline and 12 months
Goal fulfilment and satisfaction during the study period
Periodo de tiempo: Baseline and 12 months
Self-reported data
Baseline and 12 months
Self-reported physical work environment
Periodo de tiempo: Baseline and 12 months
Questionnaire based on the Swedish Work Environment Authority ergonomics checklist
Baseline and 12 months

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Self-reported fatigue the last 7 days
Periodo de tiempo: Baseline and 12 months
Numeric rating scale
Baseline and 12 months
Self-reported level of sleepiness
Periodo de tiempo: Baseline and 12 months
Karolinska Sleepiness Scale Swedish version
Baseline and 12 months
Self-reported level of sleep disturbance
Periodo de tiempo: Baseline and 12 months
Insomnia Severity Index Swedish version
Baseline and 12 months
Self-reported fear of movement
Periodo de tiempo: Baseline and 12 months
Tampa Scale for Kinesiophobia Swedish version
Baseline and 12 months
Self-reported physical activity
Periodo de tiempo: Baseline and 12 months
the National Board of Health and Welfare's three questions on physical activity, exercise, and sedentary behavior.
Baseline and 12 months
Pain catastrophizing
Periodo de tiempo: Baseline and 12 months
Pain Catastrophizing scale Swedish version
Baseline and 12 months
Perceived work ability
Periodo de tiempo: Baseline and 12 months
Work Ability Index Swedish version
Baseline and 12 months
Self-reported demands, control, and support at the workplace
Periodo de tiempo: Baseline and 12 months
Demand Control Support Questionnaire Swedish version
Baseline and 12 months
Perceived life Satisfaction
Periodo de tiempo: Baseline and 12 months
Life satisfaction Scale Swedish version
Baseline and 12 months
Self-reported work situation during the study period
Periodo de tiempo: Baseline and 12 months
Barriers for return to work, strategies to handle barriers and need of support from the employer
Baseline and 12 months
Self-reported workload an average day
Periodo de tiempo: Baseline and 12 months
Number of hours per day for paid work and unpaid household work
Baseline and 12 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Mathilda Björk, PhD, Linkoeping University

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de marzo de 2022

Finalización primaria (Anticipado)

1 de diciembre de 2023

Finalización del estudio (Anticipado)

1 de diciembre de 2024

Fechas de registro del estudio

Enviado por primera vez

24 de septiembre de 2021

Primero enviado que cumplió con los criterios de control de calidad

24 de septiembre de 2021

Publicado por primera vez (Actual)

27 de septiembre de 2021

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

25 de marzo de 2022

Última actualización enviada que cumplió con los criterios de control de calidad

9 de marzo de 2022

Última verificación

1 de marzo de 2022

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • Dnr 2019-01264

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

3
Suscribir